This article concisely summarizes data on the action of one of the principal and best known growth factors, the granulocyte colony-stimulating factor (G-CSF), in a mammalian organism exposed to radiation doses inducing acute radiation syndrome. Highlighted are the topics of its real or anticipated use in radiation accident victims, the timing of its administration, the possibilities of combining G-CSF with other drugs, the ability of other agents to stimulate endogenous G-CSF production, as well as of the capability of this growth factor to ameliorate not only the bone marrow radiation syndrome but also the gastrointestinal radiation syndrome. G-CSF is one of the pivotal drugs in the treatment of radiation accident victims and its employment in this indication can be expected to remain or even grow in the future.

Department of Molecular Cytology and Cytometry Institute of Biophysics v v i Academy of Sciences of the Czech Republic Královopolská 135 Brno CZ 612 65 Czech Republic

Zobrazit více v PubMed

Dörr H., Meineke V. Acute radiation syndrome caused by accidental radiation exposure-therapeutic principles. BMC Med. 2011;9:1–6. doi: 10.1186/1741-7015-9-1. PubMed DOI PMC

Waselenko J.K., MacVittie T.J., Blakely W.F., Pesik N., Wiley A.L., Dickerson W.E., Tsu H., Confer D.L., Coleman C.N., Seed T., et al. Medical management of the acute radiation syndrome: Recommendations of the strategic national stockpile radiation working group. Ann. Int. Med. 2004;140:1037–1051. doi: 10.7326/0003-4819-140-12-200406150-00015. PubMed DOI

Gourmelon P., Benderitter M., Bertho J.M., Huet C., Gorin N.C., de Revel P. European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal. Health Phys. 2010;98:825–832. doi: 10.1097/HP.0b013e3181ce64d4. PubMed DOI

Pellmar T.C., Rockwell S. The Radiological/Nuclear Threat Countermeasures Working Group. Priority list of research areas for radiological nuclear threat countermeasures. Radiat. Res. 2005;163:115–123. doi: 10.1667/RR3283. PubMed DOI

Nagata S. In: The Cytokine Handbook. Thomson A., editor. Academic Press; New York, NY, USA: 1994. p. 371.

Drouet M., Delaunay C., Grenier N., Garrigou P., Mayol J.F., Hérodin F. Cytokines in combination to treat radiation-induced myelosuppression: Evaluation of SCF + glycosylated EPO + pegylated G-CSF as an emergency treatment in highly irradiated monkeys. Haematol. Hematol. J. 2008;93:465–466. doi: 10.3324/haematol.12183. PubMed DOI

Moroni M., Ngudiankama B.F., Christensen C., Olsen C.H., Owens R., Lombardini E.D., Holt R.K., Whitnall M.H. The Göttingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body gamma-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2013;86:986–992. doi: 10.1016/j.ijrobp.2013.04.041. PubMed DOI PMC

Liu J.F., Du Z.D., Chen Z., Han Z.C., He Z.X. Granulocyte colony-stimulating factor attenuates monocrotaline-induced pulmonary hypertension by upregulating endothelial progenitor cells via the nitric oxide system. Exp. Therap. Med. 2013;6:1402–1408. PubMed PMC

Lee S.T., Park J.E., Kim D.H., Kim S., Im W.S., Kang L., Jung S.H., Kim M.W., Chu K., Kim M. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington’s disease. Brain Res. 2008;1194:130–137. PubMed

Metcalf D., Nicola N.A. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hematopoietic-cells. J. Cell. Physiol. 1983;116:198–206. doi: 10.1002/jcp.1041160211. PubMed DOI

Hosoi Y., Kurishita A., Ono T., Sakamoto K. Effect of recombinant human granulocyte colony-stimulating factor on survival in lethally irradiated mice. Acta Oncol. 1992;31:59–63. doi: 10.3109/02841869209088267. PubMed DOI

Marks L.B., Friedman H.S., Kurtzenberg J., Oakes W.J., Hockenberger B.M. Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor. Med. Pediatr. Oncol. 1992;20:240–242. doi: 10.1002/mpo.2950200312. PubMed DOI

Butturini A., Gale R.P., Lopes D.M., Cunha C.B., Ho W.G., Sanpai J.M., Desouza P.C., Cordiero J.M., Neto C., DeSouza C.E.P., et al. Use of recombinant granulocyte-macrophage colony stimulating factor in the Brazil radiation accident. Lancet. 1988;2:471–475. PubMed

Liu Q., Jiang B., Jiang L.P., Wu Y., Wang X.G., Zhao F.L., Fu B.H., Istvan T., Jiang E.H. Clinical report of three cases of acute radiation sickness from a 60Co radiation accident in Henan province in China. J. Radiat. Res. 2008;49:63–69. doi: 10.1269/jrr.07071. PubMed DOI

Hirama T., Tanosaki S., Kandatsu S., Kuroiwa N., Kamada T., Tsuji H., Yamada S., Katoh H., Yamamoto N., Tsujii H., et al. Initial medical management of patients severely irradiated in the Tokaimura criticality accident. Br. J. Radiol. 2003;76:246–253. doi: 10.1259/bjr/82373369. PubMed DOI

Singh V.K., Ducey E.J., Brown D.S., Whitnall M.H. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int. J. Radiat. Biol. 2012;88:296–310. doi: 10.3109/09553002.2012.652726. PubMed DOI

Dainiak N. Rationale and recommendations for treatment of radiation injury with cytokines. Health Phys. 2010;98:838–842. doi: 10.1097/HP.0b013e3181b3fce5. PubMed DOI

Hogatt J., Pelus L.M. New G-CSF agonists for neutropenia therapy. Expert Opin. Investig. Drugs. 2014;23:21–35. doi: 10.1517/13543784.2013.838558. PubMed DOI

Patchen M.L., MacVittie T.J., Solberg B.D., Souza L.M. Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression. Int. J. Cell Clon. 1990;8:107–122. doi: 10.1002/stem.5530080204. PubMed DOI

MacVittie T.J., Monroy R.L., Patchen M.L., Souza L.M. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int. J. Radiat. Biol. 1990;57:723–736. doi: 10.1080/09553009014550891. PubMed DOI

Farese A.M., Hunt P., Grab L.B., MacVittie T.J. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J. Clin. Invest. 1996;97:2145–2151. doi: 10.1172/JCI118652. PubMed DOI PMC

Dainiak N., Gent R.N., Carr Z., Schneider R., Bader J., Buglova E., Chao N., Coleman C.N., Ganser A., Gorin C., et al. First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disast. Med. Publ. Health Prepar. 2011;5:202–212. doi: 10.1001/dmp.2011.68. PubMed DOI PMC

Sureda A., Valls A., Kadar E., Algara M., Inglesesteve J., Bigas A., Jaume M., Lacruz M., Tobajas L.M., Rutlland M., et al. A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice. Exp. Hematol. 1993;21:1605–1607. PubMed

Hérodin F., Drouet M. Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival. Blood. 2003;101:2609–2616. doi: 10.1182/blood-2002-06-1634. PubMed DOI

Hérodin F., Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp. Hematol. 2005;33:1071–1080. doi: 10.1016/j.exphem.2005.04.007. PubMed DOI

Hérodin F., Drouet M. Myeloprotection following cytotoxic damage: The sooner the better. Exp. Hematol. 2008;36:769–770. doi: 10.1016/j.exphem.2008.02.005. PubMed DOI

Weiss J.F., Kumar K.S., Walden T.L., Neta R., Landauer M.R., Clark E.P. Advances in radioprotection through the use of combined agent regimen. Int. J. Biol. 1990;57:709–722. PubMed

MacVittie T.J., Farese A.M., Hérodin F., Grab L.B., Baum C.M., McKearn J.P. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor. Blood. 1996;87:4129–4135. PubMed

Patchen M.L., MacVittie T.J., Souza L.M. Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hematopoietic reconstitution and increase survival. Int. J. Radiat. Oncol. Biol. Phys. 1992;22:773–779. doi: 10.1016/0360-3016(92)90522-J. PubMed DOI

Patchen M.L. Amifostine plus granulocyte-colony-stimulating factor therapy enhances recovery from supralethal radiation exposures–Preclinical experience in animal-models. Eur. J. Cancer. 1995;31A:S17–S21. doi: 10.1016/0959-8049(95)00147-B. PubMed DOI

Hofer M., Pospisil M., Weiterova L., Hoferova Z. The role of adenosine receptor agonists in regulation of hematopoiesis. Molecules. 2011;16:675–685. PubMed PMC

Pospíšil M., Hofer M., Znojil V., Netíková J., Vácha J., Holá J., Vacek A. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice. Eur. J. Haematol. 1998;60:172–180. PubMed

Hofer M., Pospíšil M., Netíková J., Znojil V., Vácha J. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine act additively to enhance the hemopoietic spleen colony formation in irradiated mice. Physiol. Res. 1999;48:37–42. PubMed

Hofer M., Pospíšil M., Znojil V., Vacek A., Weiterová L., Holá J., Vácha J. Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: Their comparison and joint effects with granulocyte colony-stimulating factor. Eur. J. Haematol. 2002;68:4–11. doi: 10.1034/j.1600-0609.2002.00564.x. PubMed DOI

Hofer M., Pospíšil M., Šefc L., Dušek L., Vacek A., Holá J., Hoferová Z., Štreitová D. Activation of adenosine A3 receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice. Int. J. Radiat. Biol. 2010;86:649–656. doi: 10.3109/09553001003746075. PubMed DOI

Farese A.M., Yang B.B., Roskos L., Stead R.B., MacVittie T.J. Pegfilgrastim, a sustained duration form of filgrastim, significantly improves neutrophil recovery after autologous marrow transplantation in rhesus macaques. Bone Marrow Transpl. 2003;32:399–404. doi: 10.1038/sj.bmt.1704156. PubMed DOI

Farese A.M., Cohen M.V., Katz B.P., Smith C.P., Jackson W., Cohen D.M., MacVittie T.J. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 2012;103:367–382. doi: 10.1097/HP.0b013e31825f75a7. PubMed DOI PMC

Farese A.M., Cohen M.V., Katz B.P., Smith C.P., Gibbs A., Cohen D.M., MacVittie T.J. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat. Res. 2013;179:89–100. PubMed PMC

Farese A.M., Cohen M.V., Stead R.B., Jackson W., MacVittie T.J. Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques. Radiat. Res. 2012;178:403–4014. doi: 10.1667/RR2900.1. PubMed DOI

Singh P.K., Wise S.Y., Ducey E.J., Brown D.S., Singh V.K. Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine. 2011;56:411–421. doi: 10.1016/j.cyto.2011.08.016. PubMed DOI

Kulkarni S.S., Cary L.H., Gambles K., Hauer-Jensen M., Kumar K.S., Ghosh S.P. Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. Int. Immunopharmac. 2012;14:495–503. doi: 10.1016/j.intimp.2012.09.001. PubMed DOI

Singh V.K., Grace M.B., Parekh V.I., Whitnall M.H., Landauer M.R. Effects of genistein administration on cytokine production in whole-body gamma irradiated mice. Int. Immunopharmac. 2009;9:1401–1410. doi: 10.1016/j.intimp.2009.08.012. PubMed DOI

Krivokrysenko V.I., Shakhov A.N., Singh V.K., Bone F., Kononov Y., Shyshynova A., Cheney A., Maitra R.K., Purmal A., Whitnall M.H. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy a medical radiation countermeasure. J. Pharmacol. Exp. Therap. 2012;343:497–508. doi: 10.1124/jpet.112.196071. PubMed DOI PMC

Singh V.K., Shafran R.L., Inal C.E., Jackson W.E., Whitnall M.H. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol. Immunotoxicol. 2005;27:521–534. doi: 10.1080/08923970500416707. PubMed DOI

Hofer M., Pospíšil M., Holá J., Vace A., Štreitová D., Znojil V. Inhibition of cyclooxygenase 2 increases production of G-CSF and induces radioprotection. Radiat. Res. 2008;170:566–571. doi: 10.1667/RR1387.1. PubMed DOI

Hofer M., Pospíšil M., Znojil V., Holá J., Vacek A., Štreitová D. Meloxicam, an inhibitor of cyclooxygenase-2, increases the level of serum G-CSF and might be usable as an auxiliary means in G-CSF therapy. Physiol. Res. 2008;57:307–310. PubMed

Hofer M., Pospíšil M., Dušek L., Hoferová Z., Weiterová L. A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice. Radiat. Res. 2011;176:269–272. doi: 10.1667/RR2614.1. PubMed DOI

Bar-Yehuda S., Madi L., Barak D., Mittelman M., Ardon W., Ochaion A., Cohn S., Fishman P. Agonists to the A3 adenosine receptor induce G-CSF production via NF-κ B activation: A new class of myeloprotective agents. Exp. Hematol. 2002;30:1390–1398. doi: 10.1016/S0301-472X(02)00962-1. PubMed DOI

Ito K., Masuda Y., Yamasaki Y., Yokota Y., Nanba H. Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression. Int. Immunopharmacol. 2009;9:1189–1196. doi: 10.1016/j.intimp.2009.06.007. PubMed DOI

Kudo T., Matsumoto T., Nakamichi I., Yada S., Esaki M., Jo Y., Ohji Y., Yao T., Iida M. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis. Scand. J. Gastroenterol. 2008;43:689–697. doi: 10.1080/00365520701864627. PubMed DOI

Kim J.S., Ryoo S.B., Heo K., Kim J.G., Son T.G., Moon C., Yang K. Attenuating effects of granulocyte-colony stimulating factor (G-CSF) in radiation induced intestinal injury in mice. Food Chem. Toxicol. 2012;50:3174–3180. PubMed

Kim J.S., Yang M., Lee C.G., Kim S.D., Kim J.K., Yang K. In vitro and in vivo protective effects of granulocyte colony-stimulating factor against radiation-induced intestinal injury. Arch. Pharmacol. Res. 2013;36:1252–1261. doi: 10.1007/s12272-013-0164-9. PubMed DOI

Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review